findmyKOL

Scott Kasner, MD

Enriched profile

Neuroscience Clinical Development Lead, Bayer, formally retired from active University of Pennsylvania faculty (Dec 2025) and now holds Emeritus Professor of Neurology status at Penn · Bayer

ORCIDNPI
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyNeurologyFocusStroke
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1999–2024

Scott Kasner is Neuroscience Clinical Development Lead, Bayer, formally retired from active University of Pennsylvania faculty (Dec 2025) and now holds Emeritus Professor of Neurology status at Penn at Bayer. OpenAlex indexes 669 publications with 45,879 citations (h-index 89); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Scott Kasner, MD, is Neuroscience Clinical Development Lead, Bayer, formally retired from active University of Pennsylvania faculty (Dec 2025) and now holds Emeritus Professor of Neurology status at Penn. The public record shows 669 publications with 45,879 citations (h-index 89), centered on Stroke. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 17 companies, 4 NIH-funded awards (1999–2024).

  • Most recent indexed publication: 2026 · Stroke
  • Top research focus: Stroke
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Stroke3 trialsIschemic Attack, Transient2 trials

Research focus

OpenAlex concept fingerprint
Stroke

Drugs & molecules

across trials, industry payments and publications
Lokelmageneric · Sodium zirconium cyclosilicateClinical trialsIndustry payments7PublicationsS-005151Clinical trialsIndustry payments2PublicationsTnkasegeneric · TenecteplaseClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
Bayer Healthcare Pharmaceuticals Inc.Clinical trialsIndustry payments32Medtronic, Inc.Clinical trialsIndustry payments20Abbott LaboratoriesClinical trialsIndustry payments14

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
669publications

Distinct works indexed by OpenAlex, matched via ORCID; 63 in PubMed.

45,879citations

Total citations across indexed works.

89h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
4NIH grants · 1999–2024

Federally funded research awards.

View funding

Public positions

sourced statements on record
  • Chair

    American Heart Association Stroke Oversight Committee

    2010
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu
  • Associate Editor

    Journal of Stroke and Cerebrovascular Diseases

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciencedirect.com

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    50%
    Factor Xa inhibitor36.7%
    Eliquis67%Xarelto33%
    Part D<11 patients
    P2Y12 inhibitor13.3%
    Clopidogrel100%
    Part D<11 patients
  • Cardiovascular

    25.5%
    Statin13.3%
    Atorvastatin Calcium100%
    Part D<11 patients
    Calcium channel blocker12.2%
    Amlodipine Besylate100%
    Part D<11 patients
  • Nervous system

    24.5%
    Cholinesterase Inhibitor24.5%
    Donepezil Hcl100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

4 NIH research awards on record, funded 19992024 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/scott-kasner-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Scott-Kasner

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • LinkedIn

    linkedin.com/in/scott-kasner-68a088173

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • Other

    pennstroke.org/2024/04/27/dr-scott-kasner-discusses-select2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstroke.org
  • Other

    pennstroke.org/2025/12/05/farewell-to-dr-scott-kasner

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstroke.org
  • Other

    diamedica.com/company/leadership/stroke-advisory-board

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diamedica.com
3 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Vascular Neurology, American Board of Psychiatry and Neurology

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • MSCE

    Clinical Epidemiology, University of Pennsylvania

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • Board Certified

    Neurology, American Board of Psychiatry and Neurology

    1997
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • M.D.

    Yale University

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • B.S.

    Physics & Zoology, Duke University

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Emeritus Professor of Neurology

    Perelman School of Medicine, University of Pennsylvania

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • Member

    Stroke Advisory Board, DiaMedica Therapeutics, Inc.

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diamedica.com

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.